Patents by Inventor Lue Ping Zhao

Lue Ping Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9347102
    Abstract: In one embodiment, a gene expression signature for predicting risk of developing therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML) after autologous hematopoietic cell transplantation (aHCT) is provided. In another embodiment, a method for predicting a risk for development of t-MDS/AML after aHCT is provided. Such a method may include providing a biological sample that contains CD34 cells from a subject; detecting a test expression level of a set of two or more genes of a gene expression signature; comparing the test expression level of a set of corresponding training expression levels that include a training case expression level and a training control expression level; and predicting a high risk of developing t-MDS/AML when the test expression level is at or about the training case expression level or predicting a low risk of developing t-MDS/AML when the test expression level is at or about the training control expression level.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: May 24, 2016
    Assignees: CITY OF HOPE, FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventors: Ravi Bhatia, Smita Bhatia, Stephen Forman, Jerald P. Radich, Liang Li, Min Li, Lue Ping Zhao
  • Publication number: 20130274138
    Abstract: In one embodiment, a gene expression signature for predicting risk of developing therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML) after autologous hematopoietic cell transplantation (aHCT) is provided. In another embodiment, a method for predicting a risk for development of t-MDS/AML after aHCT is provided. Such a method may include providing a biological sample that contains CD34 cells from a subject; detecting a test expression level of a set of two or more genes of a gene expression signature; comparing the test expression level of a set of corresponding training expression levels that include a training case expression level and a training control expression level; and predicting a high risk of developing t-MDS/AML when the test expression level is at or about the training case expression level or predicting a low risk of developing t-MDS/AML when the test expression level is at or about the training control expression level.
    Type: Application
    Filed: June 7, 2013
    Publication date: October 17, 2013
    Inventors: Ravi Bhatia, Smita Bhatia, Stephen Forman, Jerald P. Radich, Liang Li, Min Li, Lue Ping Zhao
  • Publication number: 20030219797
    Abstract: A method for analyzing large data arrays is provided. In one aspect, the invention provides a method for analyzing data from two or more data arrays. Each array includes a plurality of members, each member provides a signal, and the data is indexed by one or more parameters. In one embodiment, the method includes fitting a model to the data; determining the goodness of the fit by evaluating the statistical significance of the fit; and determining the statistical significance of the signal. In another embodiment, the method further includes correcting the data for heterogeneity among members prior to fitting the model to the data.
    Type: Application
    Filed: February 26, 2003
    Publication date: November 27, 2003
    Applicant: Fred Hutchinson Cancer Research Center
    Inventors: Lue Ping Zhao, Ross Prentice, Linda Breeden